Early prediction of decompensation (EPOD) score: Non-invasive determination of cirrhosis decompensation risk.
Saved in:
| Title: | Early prediction of decompensation (EPOD) score: Non-invasive determination of cirrhosis decompensation risk. |
|---|---|
| Authors: | Schneider ARP; Institute of Applied Microbiology - iAMB, Aachen Biology and Biotechnology - ABBt, RWTH Aachen University, Aachen, Germany.; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Schneider CV; Division of Translational Medicine and Human Genetics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Genetics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Schneider KM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Baier V; Institute of Applied Microbiology - iAMB, Aachen Biology and Biotechnology - ABBt, RWTH Aachen University, Aachen, Germany., Schaper S; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Diedrich C; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Coboeken K; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Mayer H; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Gu W; Medical Department I, Frankfurt University Hospital, Leverkusen, Germany., Trebicka J; Medical Department I, Frankfurt University Hospital, Leverkusen, Germany.; European Foundation for Study of Chronic Liver Failure, Barcelona, Spain., Blank LM; Institute of Applied Microbiology - iAMB, Aachen Biology and Biotechnology - ABBt, RWTH Aachen University, Aachen, Germany., Burghaus R; Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany., Lippert J; Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany., Rader DJ; Division of Translational Medicine and Human Genetics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Genetics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Thaiss CA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Schlender JF; Systems Pharmacology & Medicine, Bayer AG, Leverkusen, Germany., Trautwein C; Department of Medicine III, University Hospital Aachen, Aachen, Germany., Kuepfer L; Institute for Systems Medicine, University Hospital RWTH Aachen, Aachen, Germany. |
| Source: | Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Mar; Vol. 42 (3), pp. 640-650. Date of Electronic Publication: 2022 Feb 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1478-3231 |
|---|---|
| DOI: | 10.1111/liv.15161 |
